Berbevis^® is a clinically studied, patented, phytosome^® formulation of berberine, designed using Indena’s Phytosome^® technology to boost oral bioavailability. Berberine works by activating AMPK in our body cells, often dubbed the “metabolic master switch”, helping to maintain healthy blood glucose and blood lipids.

Berbevis^® and Phytosome^® are trademarks owned by Indena S.p.A., Italy.

BPL1^® is a heat-killed postbiotic. The bioactive component of BPL-1^® lipoteichoic Acid (LTA), has been identified as the main molecule responsible for reducing abdominal fat deposition via the insulin signaling pathway.

BPL1^® is a trademark registered for Biopolis S.L. used under license.

Chromium is involved in carbohydrates, lipids, and protein metabolism. It plays a supporting role in the maintenance of healthy blood glucose regulation mainly through its effect on insulin signalling and glucose uptake.